// App-Quantinova.ai

2095 : Traditional Disease Modifying Anti-Rheumatic Drugs (tDMARDs), Hydroxychloroquine (HCQ) and/or Sulfasalazine (SSZ), Are Rapidly Effective in Immune Checkpoint Inhibitors-Induced Inflammatory Arthritis

Researchers

Presenter

  • Jessie Alperin

Principal Investigators

  • Jeffrey Sarazin

  • Leslie Fecher

  • Christopher Lao

  • Seetha Monrad

  • David Fox

Medical Centers

  • Elena Schiopu

  • University of Michigain Health System, Ann Arbor, MI

  • Rheumatology, University of Michigan Medical System, Ann Arbor, MI

  • Anesthesiology, University of Michigan Health System, Ann Arbor, MI

  • Internal Medicine, Division of Rheumatology, University of Michigan Medical Center, Ann Arbor, MI

  • Department Emergency Medicine, University of Michigan Medical School, Ann Arbor, MI

Locations

  • United States

Companies

  • N/A

Study Components

Therapeutic Area

  • Autoimmune (AI)

Disease

  • N/A

Biomarkers

  • anti-CCP antibodies

  • C reactive protein

  • Estrogen receptor alpha

Drug/Treatment

  • Hydroxychloroquine

  • Sulfasalazine

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved